ADAnna C. Duke

Anna C. Duke

*This is an algorithmically generated author record based on publicly available information.

Anna C. Duke has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Perry Nuclear Power Plant 10-mile Emergency Planning Zone Aerial Radiological Survey

    by Jonathan C. Conde, Nnss/Msts (Nnss-Msts), Anna C. Duke, William C. Beal, Matthew C. Shough, Rosario D. Trimarchi, Jacqueline C. Brandon

    The U.S. Department of Energy National Nuclear Security Administration Aerial Measuring System (AMS) conducted an aerial radiological survey of the Perry Nuclear Power Plant (Perry NPP) 10-mile Emergency Planning Zone (EPZ) from July 27 through July 30, 2026. Results are presented as terrestrial exposure rate at 1 m above ground level (AGL). Terrestrial exposure rate is defined as the exposure rate from naturally occurring radioactive materials in the Earth’s surface. Estimated contributions from airborne radon progeny, cosmic radiation, and aircraft background were removed during processing. Terrestrial exposure rates within the 10-mile EPZ were estimated to be from ≤ 2 through 4 μR/hr. The EPZ was flown at a nominal speed of 100 knots, an altitude of 500 ft AGL, with 1,000 ft flight-line spacing. Successive passes over a common test line at multiple altitudes were used to characterize the local altitude-dependent response of the terrestrial gamma-ray signal. After subtraction of these contributions, the fitted altitude-response coefficient and a calibrated counts-to-exposure-rate coefficient was used to normalize the measurements to 1 m AGL. Products are provided for point-wise measurements along the flight-paths and a spatial interpolation intended to estimate expected exposure rates between acquisition points.

  • Deep Learning enabled spectral energy conversion for in situ exposure measurements

    by Jonathan C. Conde, Diana Kauveiyakul, Anna C. Duke, Mobina Golmohammadi, William Tank, Amir A. Bahadori

  • Open Access

    The effect of rare-earth substitution on the Debye temperature of inorganic phosphors

    by Shruti Hariyani, Anna C. Duke, Thorben Krauskopf, Wolfgang G. Zeier, Jakoah Brgoch

    In the quest to predict photoluminescent efficiency in rare-earth substituted inorganic phosphors, research has shown that materials consisting of ordered, rigid crystal structures tend to possess the highest photoluminescent quantum yields. A compound's Debye temperature (ΘD), which can be calculated using ab initio calculations, is an ideal proxy for quantitatively comparing structural rigidity among different inorganic compounds, allowing potentially efficient phosphors to be selected from large crystal structure databases. However, the high computational cost of these calculations limits estimating ΘD for unsubstituted host crystal structures only. It is assumed that the low substitution concentration of the rare-earth luminescent center does not significantly influence a material's Debye temperature. This work evaluates the validity of this approximation by examining the effect of luminescent center substitution on a host structure's ΘD. Two well-known phosphors, (Y1–xCex)3Al5O12 (x = 0 − 0.05) and Ba1-δEuδMgAl10O17 (δ = 0 − 0.15), were synthesized with varying rare-earth concentrations, while ΘD was computationally estimated and then determined by ultrasonic pulse-echo speed-of-sound and low-temperature heat capacity measurements. The ensuing results provide key implications for using ΘD as a proxy for structural rigidity in substituted inorganic compounds.


  • Structure Transformation and Cerium-Substituted Optical Response across the Carbonitridosilicate Solid Solution (LaδY1−δ)2Si4N6C (δ = 0–0.5)

    by Anna C. Duke, Martin Hermus, Jakoah Brgoch

    Following an investigation proving La2Si4N6C crystallizes in a monoclinic space group, isostructural to Y2Si4N6C, the reportedly hexagonal (La0.5Y0.5)2Si4N6C was reinvestigated to examine the apparent crystal structure change across the solid solution. Initially, calculating the electronic structure and phonon density of states of (La0.5Y0.5)2Si4N6C in the P63mc space group revealed an imaginary phonon mode, which is indicative of a structural instability. Displacing the atoms along the pathway of the imaginary vibration led to a previously unreported space group for carbonitridosilicates, trigonal P31c. The assignment of the trigonal space group was subsequently confirmed by synthesizing (La0.5Y0.5)2Si4N6C using high-temperature, solid state synthesis and analyzing the crystal structure with high-resolution synchrotron X-ray powder diffraction. Preparing the solid solution, (LaδY1−δ)1.98Ce0.02Si4N6C (δ = 0–0.5), showed that the crystal structure changes from the monoclinic to the trigonal space group at δ ≈ 0.25. Finally, substituting Ce3+ in the crystal structure to investigate the optical response via steady-state luminescent and photoluminescent quantum yield measurements reveals severe luminescent quenching with increasing La3+ content, due to a combination of absorption of luminescence by the host structure and thermal quenching. These results display the virtue of combining computational and experimental techniques to solve inorganic crystal structures and assess potential phosphor hosts.


  • Open Access

    Sealing Effects on the Storage Stability of the Cyanide Antidotal Candidate, Dimethyl Trisulfide

    by Lóránd Kiss, Anna Duke, Kristof Kovacs, Tibor Barcza, Márton Kiss, Ilona Petrikovics, David E. Thompson

    Background Dimethyl trisulfide (DMTS) is a highly lipid-soluble cyanide (CN) antidote candidate molecule. In prior studies with various US FDA-approved co-solvents, surfactants, and their combinations, aqueous solutions containing 15% polysorbate 80 (Poly80) were found to effectively solubilize DMTS in formulations for intramuscular administration. However, DMTS formulated in 15% aqueous Poly80 solutions showed gradual losses over time when stored in vials with septum-based seals. Objective The present study tested whether storing DMTS formulations in hermetically sealed glass ampules could mitigate storage losses. Methods Samples consisted of 1-mL aliquots of a 50 mg/ml stock solution of DMTS in 15% aqueous Poly80. The control samples were stored using a vial-within-a-vial system—the inner and outer vials were sealed respectively, with a snap cap, and with a crimped septum. The hermetically sealed test samples were stored in fire-sealed glass ampules. The DMTS content was measured by HPLC–UV analysis at specific time points over a 100-day period. Results While the control samples exhibited systematic DMTS losses, no DMTS losses were observed from the test samples stored in hermetically sealed glass ampules over the 100-day testing period. Conclusion DMTS formulated in 15% aqueous Poly80 solution has excellent stability when stored in fire-sealed glass ampules and thus has the potential to be effectively stored as an intramuscular CN countermeasure for mass casualty scenarios.


  • Open Access

    Intravascular Residence Time Determination for the Cyanide Antidote Dimethyl Trisulfide in Rat by Using Liquid-Liquid Extraction Coupled with High Performance Liquid Chromatography

    by Deepthika De Silva, Steven Lee, Anna Duke, Siva Angalakurthi, Ching-En Chou, Afshin Ebrahimpour, David E. Thompson, Ilona Petrikovics

    These studies represent the first report on the intravascular residence time determinations for the cyanide antidote dimethyl trisulfide (DMTS) in a rat model by using high performance liquid chromatography coupled with ultraviolet absorption spectroscopy (HPLC-UV). The newly developed sample preparation included liquid-liquid extraction by cyclohexanone. The calibration curves showed a linear response for DMTS concentrations between 0.010 and 0.30 mg/mL withR2= 0.9994. The limit of detection for DMTS via this extraction method was 0.010 mg/mL, and the limit of quantitation was 0.034 mg/mL. Thus this calibration curve provided a tool for determining DMTS in the range between 0.04 and 0.30 mg/mL. Rats were given 20 mg/kg DMTS dose (in 15% Polysorbate 80) intravenously, and blood samples were taken 15, 60, 90, 120, and 240 min after DMTS injections. The data points were plotted as DMTS concentration in RBCs versus time, and the intravascular residence time was determined graphically. The results indicated a half-life of 36 min in a rat model, suggesting that the circulation time is long enough to provide a reasonable time interval for cyanide antagonism.


  • A Lipid Base Formulation for Intramuscular Administration of a Novel Sulfur Donor for Cyanide Antagonism

    by Kristof Kovacs, Prashanth Jayanna, Anna Duke, Brittany Winner, Melaeni Negrito, Siva Angalakurthi, Jorn Yu, Petra Füredi, Krisztina Ludányi, Peter Sipos, et al.

    This study represents a new formulation of the novel Cyanide (CN) antidote, Dimethyl trisulfide (DMTS), for intramuscular administration. This is a naturally occurring organosulfur molecule with the capability of reacting with CN more efficiently than the present sulfur donor type CN therapy of Thiosulfate (TS). Two types of micelles (PEG2000-DSPE and PEG2000-DSPE/TPGS) were prepared and tested for their ability to encapsulate the liquid, highly lipophilic and volatile drug, DMTS. The micellar encapsulation for DMTS does not only eliminate the possible muscle necrosis at the injection sites, but the rate of evaporation within the micelles is suppressed, that can provide a level of stability for the formulation. The method of micelle preparation was optimized and it was demonstrated that the PEG2000-DSPE preparation can dissolve up to 2.0 mg/ml of the antidote candidate. Keeping the injection volume minimized this could provide a maximum DMTS dose of 12.5 mg/kg. However, even this low dose of DMTS showed a remarkable in vivo therapeutic efficacy (2 X LD50 protection) in a mice model when injected intramuscularly. These in vitro and in vivo findings proved the efficacy of DMTS in combating CN intoxication, and the presented work gives valuable insight to micelle preparation and sets the bases for a more advanced future formulation of DMTS.